Copyright Reports & Markets. All rights reserved.

Global Sitagliptin Intermediates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sitagliptin Intermediates Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Chloropyridine Derivatives
    • 1.3.3 Fluorophenyl
    • 1.3.4 Trifluoromethylquinoline Derivatives
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sitagliptin Intermediates Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Original Drug
    • 1.4.3 Generic Drug
  • 1.5 Global Sitagliptin Intermediates Market Size & Forecast
    • 1.5.1 Global Sitagliptin Intermediates Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Sitagliptin Intermediates Sales Quantity (2020-2031)
    • 1.5.3 Global Sitagliptin Intermediates Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Acanthus Research
    • 2.1.1 Acanthus Research Details
    • 2.1.2 Acanthus Research Major Business
    • 2.1.3 Acanthus Research Sitagliptin Intermediates Product and Services
    • 2.1.4 Acanthus Research Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Acanthus Research Recent Developments/Updates
  • 2.2 CVR Life Sciences
    • 2.2.1 CVR Life Sciences Details
    • 2.2.2 CVR Life Sciences Major Business
    • 2.2.3 CVR Life Sciences Sitagliptin Intermediates Product and Services
    • 2.2.4 CVR Life Sciences Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 CVR Life Sciences Recent Developments/Updates
  • 2.3 Actis Generics
    • 2.3.1 Actis Generics Details
    • 2.3.2 Actis Generics Major Business
    • 2.3.3 Actis Generics Sitagliptin Intermediates Product and Services
    • 2.3.4 Actis Generics Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Actis Generics Recent Developments/Updates
  • 2.4 Shodhana Laboratories
    • 2.4.1 Shodhana Laboratories Details
    • 2.4.2 Shodhana Laboratories Major Business
    • 2.4.3 Shodhana Laboratories Sitagliptin Intermediates Product and Services
    • 2.4.4 Shodhana Laboratories Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Shodhana Laboratories Recent Developments/Updates
  • 2.5 Phebra
    • 2.5.1 Phebra Details
    • 2.5.2 Phebra Major Business
    • 2.5.3 Phebra Sitagliptin Intermediates Product and Services
    • 2.5.4 Phebra Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Phebra Recent Developments/Updates
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck Sitagliptin Intermediates Product and Services
    • 2.6.4 Merck Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Merck Recent Developments/Updates
  • 2.7 Ginkgo Bioworks
    • 2.7.1 Ginkgo Bioworks Details
    • 2.7.2 Ginkgo Bioworks Major Business
    • 2.7.3 Ginkgo Bioworks Sitagliptin Intermediates Product and Services
    • 2.7.4 Ginkgo Bioworks Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Ginkgo Bioworks Recent Developments/Updates
  • 2.8 Zymergen
    • 2.8.1 Zymergen Details
    • 2.8.2 Zymergen Major Business
    • 2.8.3 Zymergen Sitagliptin Intermediates Product and Services
    • 2.8.4 Zymergen Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Zymergen Recent Developments/Updates
  • 2.9 Codexis
    • 2.9.1 Codexis Details
    • 2.9.2 Codexis Major Business
    • 2.9.3 Codexis Sitagliptin Intermediates Product and Services
    • 2.9.4 Codexis Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Codexis Recent Developments/Updates
  • 2.10 Amyris
    • 2.10.1 Amyris Details
    • 2.10.2 Amyris Major Business
    • 2.10.3 Amyris Sitagliptin Intermediates Product and Services
    • 2.10.4 Amyris Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Amyris Recent Developments/Updates
  • 2.11 Novozymes
    • 2.11.1 Novozymes Details
    • 2.11.2 Novozymes Major Business
    • 2.11.3 Novozymes Sitagliptin Intermediates Product and Services
    • 2.11.4 Novozymes Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Novozymes Recent Developments/Updates
  • 2.12 Amgen
    • 2.12.1 Amgen Details
    • 2.12.2 Amgen Major Business
    • 2.12.3 Amgen Sitagliptin Intermediates Product and Services
    • 2.12.4 Amgen Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Amgen Recent Developments/Updates
  • 2.13 Abiochem Biotechnology
    • 2.13.1 Abiochem Biotechnology Details
    • 2.13.2 Abiochem Biotechnology Major Business
    • 2.13.3 Abiochem Biotechnology Sitagliptin Intermediates Product and Services
    • 2.13.4 Abiochem Biotechnology Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Abiochem Biotechnology Recent Developments/Updates
  • 2.14 Yongtai Technology
    • 2.14.1 Yongtai Technology Details
    • 2.14.2 Yongtai Technology Major Business
    • 2.14.3 Yongtai Technology Sitagliptin Intermediates Product and Services
    • 2.14.4 Yongtai Technology Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Yongtai Technology Recent Developments/Updates
  • 2.15 Longlife Bio-Pharmaceutical
    • 2.15.1 Longlife Bio-Pharmaceutical Details
    • 2.15.2 Longlife Bio-Pharmaceutical Major Business
    • 2.15.3 Longlife Bio-Pharmaceutical Sitagliptin Intermediates Product and Services
    • 2.15.4 Longlife Bio-Pharmaceutical Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Longlife Bio-Pharmaceutical Recent Developments/Updates
  • 2.16 Infinity Scientific
    • 2.16.1 Infinity Scientific Details
    • 2.16.2 Infinity Scientific Major Business
    • 2.16.3 Infinity Scientific Sitagliptin Intermediates Product and Services
    • 2.16.4 Infinity Scientific Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Infinity Scientific Recent Developments/Updates
  • 2.17 Furui Biopharma Technology
    • 2.17.1 Furui Biopharma Technology Details
    • 2.17.2 Furui Biopharma Technology Major Business
    • 2.17.3 Furui Biopharma Technology Sitagliptin Intermediates Product and Services
    • 2.17.4 Furui Biopharma Technology Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 Furui Biopharma Technology Recent Developments/Updates
  • 2.18 Arromax Pharmatech
    • 2.18.1 Arromax Pharmatech Details
    • 2.18.2 Arromax Pharmatech Major Business
    • 2.18.3 Arromax Pharmatech Sitagliptin Intermediates Product and Services
    • 2.18.4 Arromax Pharmatech Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Arromax Pharmatech Recent Developments/Updates
  • 2.19 Yisheng Pharmaceutical
    • 2.19.1 Yisheng Pharmaceutical Details
    • 2.19.2 Yisheng Pharmaceutical Major Business
    • 2.19.3 Yisheng Pharmaceutical Sitagliptin Intermediates Product and Services
    • 2.19.4 Yisheng Pharmaceutical Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 Yisheng Pharmaceutical Recent Developments/Updates
  • 2.20 Zhenlei Chemical
    • 2.20.1 Zhenlei Chemical Details
    • 2.20.2 Zhenlei Chemical Major Business
    • 2.20.3 Zhenlei Chemical Sitagliptin Intermediates Product and Services
    • 2.20.4 Zhenlei Chemical Sitagliptin Intermediates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Zhenlei Chemical Recent Developments/Updates

3 Competitive Environment: Sitagliptin Intermediates by Manufacturer

  • 3.1 Global Sitagliptin Intermediates Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Sitagliptin Intermediates Revenue by Manufacturer (2020-2025)
  • 3.3 Global Sitagliptin Intermediates Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Sitagliptin Intermediates by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Sitagliptin Intermediates Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Sitagliptin Intermediates Manufacturer Market Share in 2024
  • 3.5 Sitagliptin Intermediates Market: Overall Company Footprint Analysis
    • 3.5.1 Sitagliptin Intermediates Market: Region Footprint
    • 3.5.2 Sitagliptin Intermediates Market: Company Product Type Footprint
    • 3.5.3 Sitagliptin Intermediates Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sitagliptin Intermediates Market Size by Region
    • 4.1.1 Global Sitagliptin Intermediates Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Sitagliptin Intermediates Consumption Value by Region (2020-2031)
    • 4.1.3 Global Sitagliptin Intermediates Average Price by Region (2020-2031)
  • 4.2 North America Sitagliptin Intermediates Consumption Value (2020-2031)
  • 4.3 Europe Sitagliptin Intermediates Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Sitagliptin Intermediates Consumption Value (2020-2031)
  • 4.5 South America Sitagliptin Intermediates Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Sitagliptin Intermediates Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Sitagliptin Intermediates Sales Quantity by Type (2020-2031)
  • 5.2 Global Sitagliptin Intermediates Consumption Value by Type (2020-2031)
  • 5.3 Global Sitagliptin Intermediates Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Sitagliptin Intermediates Sales Quantity by Application (2020-2031)
  • 6.2 Global Sitagliptin Intermediates Consumption Value by Application (2020-2031)
  • 6.3 Global Sitagliptin Intermediates Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Sitagliptin Intermediates Sales Quantity by Type (2020-2031)
  • 7.2 North America Sitagliptin Intermediates Sales Quantity by Application (2020-2031)
  • 7.3 North America Sitagliptin Intermediates Market Size by Country
    • 7.3.1 North America Sitagliptin Intermediates Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Sitagliptin Intermediates Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Sitagliptin Intermediates Sales Quantity by Type (2020-2031)
  • 8.2 Europe Sitagliptin Intermediates Sales Quantity by Application (2020-2031)
  • 8.3 Europe Sitagliptin Intermediates Market Size by Country
    • 8.3.1 Europe Sitagliptin Intermediates Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Sitagliptin Intermediates Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sitagliptin Intermediates Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Sitagliptin Intermediates Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Sitagliptin Intermediates Market Size by Region
    • 9.3.1 Asia-Pacific Sitagliptin Intermediates Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Sitagliptin Intermediates Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Sitagliptin Intermediates Sales Quantity by Type (2020-2031)
  • 10.2 South America Sitagliptin Intermediates Sales Quantity by Application (2020-2031)
  • 10.3 South America Sitagliptin Intermediates Market Size by Country
    • 10.3.1 South America Sitagliptin Intermediates Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Sitagliptin Intermediates Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sitagliptin Intermediates Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Sitagliptin Intermediates Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Sitagliptin Intermediates Market Size by Country
    • 11.3.1 Middle East & Africa Sitagliptin Intermediates Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Sitagliptin Intermediates Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Sitagliptin Intermediates Market Drivers
  • 12.2 Sitagliptin Intermediates Market Restraints
  • 12.3 Sitagliptin Intermediates Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sitagliptin Intermediates and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sitagliptin Intermediates
  • 13.3 Sitagliptin Intermediates Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sitagliptin Intermediates Typical Distributors
  • 14.3 Sitagliptin Intermediates Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Sitagliptin Intermediates market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    Sitagliptin intermediates are key chemical components used to synthesize sitagliptin, an anti-diabetic drug. Sitagliptin is a DPP-4 inhibitor that helps regulate blood sugar levels by inhibiting dipeptidyl peptidase-4 (DPP-4). Its synthesis requires multiple different types of intermediates to gradually build the main structure of the drug and introduce key functional groups.
    This report is a detailed and comprehensive analysis for global Sitagliptin Intermediates market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Sitagliptin Intermediates market size and forecasts, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2020-2031
    Global Sitagliptin Intermediates market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2020-2031
    Global Sitagliptin Intermediates market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilotons), and average selling prices (US$/Ton), 2020-2031
    Global Sitagliptin Intermediates market shares of main players, shipments in revenue ($ Million), sales quantity (Kilotons), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Sitagliptin Intermediates
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Sitagliptin Intermediates market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Acanthus Research, CVR Life Sciences, Actis Generics, Shodhana Laboratories, Phebra, Merck, Ginkgo Bioworks, Zymergen, Codexis, Amyris, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Sitagliptin Intermediates market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Chloropyridine Derivatives
    Fluorophenyl
    Trifluoromethylquinoline Derivatives
    Others
    Market segment by Application
    Original Drug
    Generic Drug
    Major players covered
    Acanthus Research
    CVR Life Sciences
    Actis Generics
    Shodhana Laboratories
    Phebra
    Merck
    Ginkgo Bioworks
    Zymergen
    Codexis
    Amyris
    Novozymes
    Amgen
    Abiochem Biotechnology
    Yongtai Technology
    Longlife Bio-Pharmaceutical
    Infinity Scientific
    Furui Biopharma Technology
    Arromax Pharmatech
    Yisheng Pharmaceutical
    Zhenlei Chemical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Sitagliptin Intermediates product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Sitagliptin Intermediates, with price, sales quantity, revenue, and global market share of Sitagliptin Intermediates from 2020 to 2025.
    Chapter 3, the Sitagliptin Intermediates competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Sitagliptin Intermediates breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sitagliptin Intermediates market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Sitagliptin Intermediates.
    Chapter 14 and 15, to describe Sitagliptin Intermediates sales channel, distributors, customers, research findings and conclusion.

    Buy now